Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 12Papillomavirus Infections 11Neoplasms 10Breast Neoplasms 9Uterine Cervical Dysplasia 7Persistent Infection 5Condylomata Acuminata 5Prostatic Neoplasms 4Melanoma 4Anus Neoplasms 4Vulvar Neoplasms 3Lung Neoplasms 3Herpes Zoster 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Vaginal Neoplasms 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Influenza, Human 2HIV Infections 2Glioma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

pandemrix 1lactitol 1halofantrine 1focetria 1Vaccines 1Health Information Exchange 1COVID-19 Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rheumatic Diseases × Vaccines × Clear all
NCT01022905 2010-03-01

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

University Hospital, Geneva

Phase 4 Completed
1,141 enrolled

Neoplasms, Rheumatic Diseases, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡